4 results
The aim of this study is to investigate what proportion of HBeAg negative, inactive carriers of the hepatitis B virus with low (< 20,000 IU/mL) load will lose HBsAg when treated with nucleot(s)ide analogue/Peg-IFN combination therapy.
To ascertain whether the survival time distribution for patients randomized to the investigational arm is consistent with longer survival as compared to patients randomized to the control arm.
Primary Objective:Our primary objective is to investigate the changes in CSR of the lower trunk muscles in subjects with an episode of recurrent LBP and compare them with healthy subjects.Secondary Objective(s):Our secondary objective is to explore…
Single-pulse TMS will be applied across the primary motor cortex to address corticospinal pathways, resulting in a response in the electromyographic signal of the target muscles. The primary objective of the experiment described by this amendment is…